TY - JOUR
T1 - Fusion technique does not affect short-term patient-reported outcomes for lumbar degenerative disease
AU - Divi, Srikanth N.
AU - Schroeder, Gregory D.
AU - Goyal, Dhruv K.C.
AU - Radcliff, Kristen E.
AU - Galetta, Matthew S.
AU - Hilibrand, Alan S.
AU - Anderson, D. Greg
AU - Kurd, Mark F.
AU - Rihn, Jeffrey A.
AU - Kaye, Ian D.
AU - Woods, Barrett R.
AU - Vaccaro, Alexander R.
AU - Kepler, Christopher K.
N1 - Funding Information:
Author disclosures: SND: Nothing to disclose. GDS: Board of Directors: CSRS, Clinical Spine Surgery (Nonfinancial); Consulting: Zimmer (C), Stryker (C), Advanced Medical (C), Medtronic (C); Trips/Travel: AOSpine (C). DKCG: Nothing to disclose. KER: Consulting: Advance Medical (C), Medtronic Advanced Energy (B), Stryker (D, Paid directly to institution/employer), Zimmer Biomet LDR Spine (Nonfinancial); Research Support (Investigator Salary): Ferring Pharmaceuticals (A); Research Support (Staff and/or materials): Simplify Medical (A, Paid directly to institution/employer); Royalties: Globus Medical (B), Orthopedic Sciences (A); Scientific Advisory Board: 4WEB Medical (None); Stock Ownership (including options, warrants): 4WEB Medical (Future Compensation Expected, 50,000 shares), Rothman Institute (Future Compensation Expected, 2%); Trips/Travel: Lilly (A), Zimmer Biomet LDR (B, Travel Expense Reimbursement). MSG: Nothing to disclose: ASH: Board of Directors: AAOS (Chair of Communications Cabinet, Treasurer); Device or Biologic Distribution Group (Physician-Owned Distributorship): Amedica (D), Biomet Spine (G); Private Investments (including venture capital, start-ups): Paradigm Spine (B), VertiFlex (B); Stock Ownership (including options, warrants): Amedica (<1%), Life Spine (<1%), Spinal Ventures (3%). DGA: Consulting: DePuy Synthes Spine (C), Integrity Spine (D), K2M (C); Private Investments: ISD (Nonfinancial); Royalties: DePuy Synthes Spine (F). MFK: Consulting: K2M (B); Private Investments (including venture capital, start-ups): Dura Tap (10.5%); Speaking and/or Teaching Arrangements: Philadelphia Spine Society (Director). JAR: Board of Directors: Cervical Spine Research Society (None), Juvenile Diabetes Research Foundation (None), NASS The Spine Journal (Deputy Editor); Consulting: Globus Medical (B); Stock Ownership (including options, warrants): Xtant Medical (30,000 shares). IDK: Nothing to disclose. BRW: Consulting: Altus (D, Paid directly to institution/employer), Precision (B), Titan (D); Device or Biologic Distribution Group (Physician-Owned Distributorship): Altus (B); Speaking and/or Teaching Arrangements: Stryker (C). ARV: Board of Directors: AOSpine (Knowledge Forum Director), Flagship Surgical (None), Innovative Surgical Design (None), Parvizi Surgical Innovation (Nonfinancial), Prime Surgeons (Nonfinancial), Progressive Spinal Technologies (Nonfinancial), Spine Therapy Network (Nonfinancial); Consulting: Atlas Spine (B), DePuy (None), Gerson Lehrman Group (None), Globus (C), Guidepoint Global (B), Innovative Surgical Design (None), Medtronic (B), NuVasive (None), Orthobullets (None), Spine Wave (B), Stout Medical (None), Stryker Spine (F); Other: Clinical Spine Surgery (Editor in Chief); Royalties: Elsevier (B), Globus (F), Jaypee Books (A), Medtronic (E), Stryker Spine (F), Taylor Francis (A), Thieme (B); Stock Ownership (including options, warrants): Advanced Spinal Intellectual Properties (30%), Avaz Surgical (<1%), Bonovo Orthopaedics (<1%), Computational Biodynamics (<1%), Cytonics (<1%), Dimension Orthotics (<1%), ElectroCore (D), Flagship Surgical (<1%), Flow Pharma (<1%), Franklin Bioscience (<1%), Globus (111,098 shares), Innovative Surgical Design (<1%), Insight Therapeutics (<1%), NuVasive (<1%), Paradigm Spine (<1%), Parvizi Surgical Innovation (<1%), Prime Surgeons (<1%), Progressive Spinal Technology (<1%), Replication Medica (<1%), Spine Medica (<1%), Spineology (<1%), Stout Medical (631 shares), VertiFlex (<1%). CKK: Grants: NIH (I, Paid directly to institution/employer); Other Office: Clinical Spine Surgery (Nonfinancial); Research Support (Staff and/or materials): CSRS (D, Paid directly to institution/employer), RTI (C, Paid directly to institution/employer), RTI (C, Paid directly to institution/employer); Royalties: Inion (None). Conflicts of Interest and Source of Funding: The authors, their immediate family, and any research foundation with which they are affiliated did not receive any financial payments or other benefits from any commercial entity related to the subject of this article. There are no relevant disclosures.
Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/12
Y1 - 2019/12
N2 - Background/Context: Degenerative lumbar disease can be addressed via an anterior or posterior approach, and with or without the use of an interbody cage. Although several studies have compared the type of approach and technique, there is a lack of literature assessing patient-reported outcome measures (PROMs) and radiographic parameters between different fusion techniques. Purpose: To determine whether the surgical approach and fusion technique for lumbar degenerative disease had an effect on short-term PROMs and radiographic parameters. Study Design/Setting: Retrospective Cohort Study. Patient Sample: Three hundred and ninety-one patients who underwent a 1–3 level lumbar spine fusion procedure at a high-volume academic center were retrospectively identified. Patients were divided into three groups based on the type of fusion they underwent: posterolateral fusion (PLF), anterior lumbar interbody fusion (ALIF), or transforaminal lumbar interbody fusion (TLIF). Outcome Measures: PROMs: Short Form-12 (SF-12) Physical Component Score (PCS) and Mental Component Score (MCS), Oswestry Disability Index (ODI), Visual Analog Score (VAS) Back, VAS Leg. Spinopelvic measurements: Pelvic Tilt (PT), Sacral Slope (SS), Pelvic Incidence (PI), Lumbar Lordosis (LL), Segmental Lordosis (SL), PI–LL mismatch. Methods: Patients with less than 1-year follow-up were excluded from the cohort. Pre- and postoperative spinopelvic measurements were obtained for all patients. Univariate analysis (Chi-squared/Fisher's exact test or ANOVA test with post-hoc Bonferroni test) was used to compare among the three groups in the PROMs and radiographic spinopelvic parameters. Multiple linear regression was used to determine if fusion technique was an independent predictor of change in each patient outcome. Results: Two hundred and sixteen patients were included in the PLF group, 33 patients in the ALIF group, and 142 patients in the TLIF group. The PLF group was significantly older at baseline (p<.001) and had lower preoperative diagnosis rates of degenerative scoliosis and disc herniations (p<.001), whereas the ALIF group underwent a higher proportion of three-level fusions (p<.001). There was no significant difference in spinopelvic parameters preoperatively, however the ALIF group showed significantly more improvement in SL postoperatively (p=.004) than the PLF and TLIF groups. Within each group, SL improved for the PLF and ALIF groups (p=.002 for both), but not for the TLIF group (p=.238). Comparing patient outcomes, the ALIF group reported lower preoperative VAS Leg scores (p=.031), however, this difference resolved postoperatively. Stratifying for preoperative diagnosis, there were no significant differences in outcomes, except for a greater improvement in VAS Leg scores for degenerative scoliosis patients undergoing ALIF. Using multivariate analysis, fusion technique was not found to be a significant predictor of change in any patient outcome or in odds of revision. Conclusions: Lumbar degenerative disease can be treated with several different fusion techniques, however, the relationship between type of fusion and PROMs is not established. Based on the findings in this study, the ALIF group showed greater improvement in SL compared with the PLF and TLIF groups, however, there was no difference noted in overall LL, PI–LL mismatch or other spinopelvic parameters. Despite these radiographic findings, patient outcome measures remained similar between all three fusion types.
AB - Background/Context: Degenerative lumbar disease can be addressed via an anterior or posterior approach, and with or without the use of an interbody cage. Although several studies have compared the type of approach and technique, there is a lack of literature assessing patient-reported outcome measures (PROMs) and radiographic parameters between different fusion techniques. Purpose: To determine whether the surgical approach and fusion technique for lumbar degenerative disease had an effect on short-term PROMs and radiographic parameters. Study Design/Setting: Retrospective Cohort Study. Patient Sample: Three hundred and ninety-one patients who underwent a 1–3 level lumbar spine fusion procedure at a high-volume academic center were retrospectively identified. Patients were divided into three groups based on the type of fusion they underwent: posterolateral fusion (PLF), anterior lumbar interbody fusion (ALIF), or transforaminal lumbar interbody fusion (TLIF). Outcome Measures: PROMs: Short Form-12 (SF-12) Physical Component Score (PCS) and Mental Component Score (MCS), Oswestry Disability Index (ODI), Visual Analog Score (VAS) Back, VAS Leg. Spinopelvic measurements: Pelvic Tilt (PT), Sacral Slope (SS), Pelvic Incidence (PI), Lumbar Lordosis (LL), Segmental Lordosis (SL), PI–LL mismatch. Methods: Patients with less than 1-year follow-up were excluded from the cohort. Pre- and postoperative spinopelvic measurements were obtained for all patients. Univariate analysis (Chi-squared/Fisher's exact test or ANOVA test with post-hoc Bonferroni test) was used to compare among the three groups in the PROMs and radiographic spinopelvic parameters. Multiple linear regression was used to determine if fusion technique was an independent predictor of change in each patient outcome. Results: Two hundred and sixteen patients were included in the PLF group, 33 patients in the ALIF group, and 142 patients in the TLIF group. The PLF group was significantly older at baseline (p<.001) and had lower preoperative diagnosis rates of degenerative scoliosis and disc herniations (p<.001), whereas the ALIF group underwent a higher proportion of three-level fusions (p<.001). There was no significant difference in spinopelvic parameters preoperatively, however the ALIF group showed significantly more improvement in SL postoperatively (p=.004) than the PLF and TLIF groups. Within each group, SL improved for the PLF and ALIF groups (p=.002 for both), but not for the TLIF group (p=.238). Comparing patient outcomes, the ALIF group reported lower preoperative VAS Leg scores (p=.031), however, this difference resolved postoperatively. Stratifying for preoperative diagnosis, there were no significant differences in outcomes, except for a greater improvement in VAS Leg scores for degenerative scoliosis patients undergoing ALIF. Using multivariate analysis, fusion technique was not found to be a significant predictor of change in any patient outcome or in odds of revision. Conclusions: Lumbar degenerative disease can be treated with several different fusion techniques, however, the relationship between type of fusion and PROMs is not established. Based on the findings in this study, the ALIF group showed greater improvement in SL compared with the PLF and TLIF groups, however, there was no difference noted in overall LL, PI–LL mismatch or other spinopelvic parameters. Despite these radiographic findings, patient outcome measures remained similar between all three fusion types.
KW - ALIF
KW - Lumbar approach
KW - Lumbar fusion
KW - PLF
KW - PROM
KW - Patient reported outcome measures
KW - Spinopelvic parameters
KW - TLIF
UR - http://www.scopus.com/inward/record.url?scp=85071086627&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85071086627&partnerID=8YFLogxK
U2 - 10.1016/j.spinee.2019.07.014
DO - 10.1016/j.spinee.2019.07.014
M3 - Article
C2 - 31356987
AN - SCOPUS:85071086627
SN - 1529-9430
VL - 19
SP - 1960
EP - 1968
JO - Spine Journal
JF - Spine Journal
IS - 12
ER -